Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Northern Medical Inc.

Latest From Northern Medical Inc.

Keeping Track: A Quintet Of Novel Approvals

The latest drug development news and highlights from our US FDA Performance Tracker. 

Approvals Drug Review

Pfizer’s Vizimpro On Course For India But Competitive Arena Awaits

Pfizer’s Vizimpro has been endorsed by an expert panel in India, paving the way for its potential introduction on the market, where other EGFR inhibitors including AstraZeneca’s Tagrisso have a head start.

India Approvals

Basilea-Pfizer’s Cresemba Heads For Indian Debut

Basilea’s Cresemba appears on course to a debut in India and partner Pfizer expects the novel antifungal to bolster its existing portfolio in the segment. Pricing of the product will be keenly watched.

Policy & Regulation India

GSK Forms New Commercial Trade Channel Team In India

GlaxoSmithKline India has carved out a specialized team with close to 300 personnel to engage with pharmacists. It is seeking to plug product availability gaps and address Rx switching at the retail level in the competitive and largely out-of-pocket Indian market.

Commercial Strategy
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Parent & Subsidiaries
  • Northern Medical Inc.
  • Senior Management
  • Contact Info
  • Northern Medical Inc.
    ,
Advertisement
Advertisement
UsernamePublicRestriction

Register